NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for end-stage renal disease


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Kidney Patients Heart Health is Getting Better
2009 NOV 23 ... published comprehensive guidelines on evaluating and treating cardiovascular disease in end-stage renal disease patients treated with dialysis or transplant. These guidelines helped boost awareness of ...
Subject: Heart Disease
Price: $3.00
*
Nephros Reports 2009 Third Quarter Financial Results
2009 NOV 23 ... 2009, Nephros had cash and cash equivalents in the amount of $1,795,000. End-Stage Renal Disease (ESRD) Products Nephros completed the patient treatment phase of the U.S. ...
Subject: Nephros, Inc.
Price: $3.00
*
New data from University of Pittsburgh illuminate research in monoclonal antibodies
2009 NOV 23 ... "Calcineurin inhibitor nephrotoxicity in nonrenal allograft recipients can lead to end-stage renal disease and the need for kidney transplantation. We sought to evaluate the role of alemtuzumab ...
Subject: Monoclonal Antibodies
Price: $3.00
*
New dialysis research has been reported by scientists at State University of New York
2009 NOV 23 ... in the United States report. "Both conditions are extremely uncommon in end-stage renal disease patients on dialysis. We report the first known case of combined chylothorax and chylous ...
Subject: Dialysis
Price: $3.00
*
New dialysis study findings have been reported from L. Troidle et al
2009 NOV 23 ... in the dialysis technique and increasing urea Kt/V have not improved outcomes for end-stage renal disease patients maintained on hemodialysis (HD) therapy. Attention has, thus, focused on ...
Subject: Dialysis
Price: $3.00
*
New findings from Veterans Affairs Medical Center in the area of kidney failure cell biology described
2009 NOV 24 ... "When patients develop acute kidney injury, a small fraction of them will develop end-stage renal disease later. The severity of renal impairment in the remaining patients is uncertain because ...
Subject: Kidney Failure Cell Biology
Price: $3.00
*
New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options
2009 NOV 23 ... own care," said James Sloand, M.D., senior medical director of Baxter's North American Renal business. "This program empowers individuals to take measures to slow the progression ... implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such ...
Subject: Baxter International Inc.
Price: $3.00
*
Reports from Vanderbilt University add new data to research in dialysis
2009 NOV 24 ... a substantial fraction of dialysis patients. It is generally unknown what proportion of end-stage renal disease patients on dialysis could recover kidney function if RAS were treated." ...
Subject: Dialysis
Price: $3.00
*
Reports outline renal disease study results from University of California
2009 NOV 23 ... "Rates of chronic kidney disease and end-stage renal disease are increasing as the United States population ages. The elderly with chronic kidney ...
Subject: Renal Disease
Price: $3.00
*
Reports summarize fistula research from M.T. James and co-authors
2009 NOV 24 ... of vascular access for chronic hemodialysis. Unfortunately, in a subset of patients with end-stage renal disease, an AVF cannot be placed or fails to mature. In these patients an alternate form of ...
Subject: Fistula
Price: $3.00
*
Research findings from R.N. Foley et al update understanding of fistula
2009 NOV 23 ... mean patient age was 63.6 years; 29.4% of patients were African American, and for 44.5%, end-stage renal disease was due to diabetes. Vascular access proportions were: fistula, 13.2% of patients; ...
Subject: Fistula
Price: $3.00
*
Research from B.K. Kim and co-researchers yields new findings on thrombosis
2009 NOV 23 ... and Stent Thrombosis of Sirolimus-Eluting Versus Bare Metal Stents in Patients with End-Stage Renal Disease: Results of Korean Multicenter Angioplasty Team (KOMATE) Registry. Journal of ...
Subject: Thrombosis
Price: $3.00
*
Research from K.C. Young and colleagues provide new insights into hypertension
2009 NOV 23 ... utilities, and event rates for future myocardial infarction, stroke, heart failure, and end-stage renal disease were modeled. Sensitivity analyses tested the assumptions in the model. The incremental ...
Subject: Hypertension
Price: $3.00
*
Research from L. Delvecchio and co-authors in the area of renal disease published
2009 NOV 23 ... medical care and dialysis delivery, mortality and morbidity remain high in patients with end-stage renal disease. This is particularly true in older patients, who often have a great number of ...
Subject: Renal Disease
Price: $3.00
*
Research on renal disease discussed by M. Davins and co-researchers
2009 NOV 23 ... Davins and colleagues published their study in Vascular (Aortofemoral Bypass to Bridge End-Stage Renal Disease Patients with Severe Iliac Calcification to Kidney Transplantation. Vascular, ...
Subject: Renal Disease
Price: $3.00
*
Research on secondary hyperparathyroidism detailed by M. Thompson and co-authors
2009 NOV 24 ... According to recent research from the United States, "A 25-year-old patient with end-stage renal disease on maintenance peritoneal dialysis underwent parathyroidectomy when his secondary ...
Subject: Secondary Hyperparathyroidism
Price: $3.00
*
Study findings from Indiana University provide new insights into cardioprotection
2009 NOV 23 ... Cardioprotection, Cardiovascular, Echocardiography, Enzymes, Hemodialysis, Nephrology, Renal Dialysis, Therapy, Treatment, Indiana University. This article was prepared ... According to a study from the United States, "Kidney/Disease Outcome Quality Initiative (K/DOQI) guidelines recommend baseline echocardiography at ...
Subject: Cardioprotection
Price: $3.00
*
Study results from Columbia University in the area of hypotension published
2009 NOV 23 ... inter- and intradialytic blood pressure control, and, ultimately, clinical outcomes in end-stage renal disease patients on dialysis." Thompson and colleagues published their study in ...
Subject: Hypotension
Price: $3.00
*
Study results from M. Bohlke and colleagues in the area of quality of life published
2009 NOV 23 ... a study from Pelotas, Brazil, "Kidney transplantation improves the quality of life of end-stage renal disease patients. The quality of life benefits, however, pertain to patients on average, not to ...
Subject: Quality of Life
Price: $3.00
*
Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
2009 NOV 23 ... blocker (ARB) drug therapies has been shown to reduce blood pressure and associated renal and cardiovascular events. About Hypertension and End-Organ Diseases Hypertension is a ... recognized by Windhover as a "Top 10 Project to Watch" in the cardiovascular/metabolic disease category. Top 10 projects in four therapeutic areas will be highlighted at Windhover's ...
Subject: Vitae Pharmaceuticals, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login